ACHILLION PHARMACEUTICALS INC Contracts & Agreements

Sublease Agreement by and between the Registrant and Yale University, dated as of September 13, 2019 (Filed With SEC on November 7, 2019)

Agreement and Plan of Merger, dated October 15, 2019, by and among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc., and Beagle Merger Sub, Inc (Filed With SEC on October 16, 2019)

Non-Executive Directors Compensation Policy, dated December 12, 2018 (Filed With SEC on March 7, 2019)

Employment Agreement, dated February 11, 2019, by and between Achillion Pharmaceuticals, Inc. and Brian Di Donato (Filed With SEC on February 11, 2019)

Lease Agreement, dated as of July 20, 2018, by and between Achillion Pharmaceuticals, Inc. and Sentry KPG III, L.P (Filed With SEC on December 4, 2018)

Amendment to Lease, dated as of November 30, 2018, by and between Achillion Pharmaceuticals, Inc. and Sentry KPG III, L.P (Filed With SEC on December 4, 2018)

Letter Agreement, dated November 20, 2018, by and between Achillion Pharmaceuticals, Inc. and Mary Kay Fenton (Filed With SEC on November 21, 2018)

Employment Agreement, dated August 15, 2018, by and between the Registrant and Anthony Gibney (Filed With SEC on November 7, 2018)

Employment Agreement, dated August 20, 2018, by and between the Registrant and Steven Zelenkofske (Filed With SEC on November 7, 2018)

Employment Agreement, dated September 10, 2018, by and between the Registrant and Paul Firuta (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form... (Filed With SEC on November 7, 2018)

Employment Agreement, dated September 10, 2018, by and between Achillion Pharmaceuticals, Inc. and Paul Firuta (Filed With SEC on September 10, 2018)

Consulting Agreement, dated May 18, 2018, by and between the Registrant and Milind Deshpande (Filed With SEC on August 8, 2018)

Amended and Restated 2015 Stock Incentive Plan (Filed With SEC on August 8, 2018)

Letter Agreement, dated May 23, 2018, by and between the Registrant and Milind Deshpande (Filed With SEC on August 8, 2018)

Second Amended and Restated Employment Agreement, dated May 1, 2018, by and between the Registrant and Joseph Truitt (Filed With SEC on May 2, 2018)

Underwriting Agreement, dated November 15, 2017, by and among the Company, Goldman Sachs & Co. LLC and Leerink Partners LLC, as representatives of the underwriters named therein... (Filed With SEC on November 16, 2017)

Letter Agreement, dated November 14, 2017, by and between the Company and Johnson & Johnson Innovation-JJDC, Inc (Filed With SEC on November 16, 2017)

Form of Inducement Grant Nonstatutory Stock Option Agreement (Filed With SEC on November 1, 2017)

Amendment No. 5 to Lease, dated as of October 3, 2017, by and between and Achillion Pharmaceuticals, Inc. and WE George Street, LLC (Filed With SEC on November 1, 2017)

Amended and Restated Employment Agreement, dated August 4, 2017, by and between Achillion Pharmaceuticals, Inc. and Milind S. Deshpande (Filed With SEC on August 8, 2017)

Amended and Restated Employment Agreement, dated August 4, 2017, by and between Achillion Pharmaceuticals, Inc. and Mary Kay Fenton (Filed With SEC on August 8, 2017)

Amended and Restated Employment Agreement, dated August 4, 2017, by and between Achillion Pharmaceuticals, Inc. and David Apelian (Filed With SEC on August 8, 2017)

Amended and Restated Employment Agreement, dated August 4, 2017, by and between Achillion Pharmaceuticals, Inc. and Joseph Truitt (Filed With SEC on August 8, 2017)

Amended and Restated Employment Agreement, dated August 4, 2017, by and between Achillion Pharmaceuticals, Inc. and Martha Manning (Filed With SEC on August 8, 2017)

First Amendment to Master Security Agreement between Achillion Pharmaceuticals, Inc. and Webster Bank, National Association, dated as of May 26, 2016, as further amended on July... (Filed With SEC on August 8, 2017)

ACHILLION PHARMACEUTICALS, INC. Non-Executive Directors Compensation Policy (Filed With SEC on May 4, 2017)

ACHILLION PHARMACEUTICALS, INC. $75,000,000 of Shares of CommonStock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on February 23, 2017)

THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on December 28, 2016)

FIRST AMENDMENT TO MASTER SECURITY AGREEMENT (Filed With SEC on May 27, 2016)

AMENDMENT NO. 4 TO LEASE (Filed With SEC on April 8, 2016)

Achillion Pharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2015 Stock Incentive Plan (Filed With SEC on February 25, 2016)

Achillion Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement Granted Under 2015 Stock Incentive Plan (Filed With SEC on February 25, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on February 25, 2016)

Non-Executive Directors Compensation Policy (Filed With SEC on February 25, 2016)

AMENDMENT NO. 3 TO LEASE (Filed With SEC on August 24, 2015)

ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 10, 2015)

STOCKPURCHASE AGREEMENT By and Between JOHNSON & JOHNSON INNOVATION-JJDC, INC. AND ACHILLIONPHARMACEUTICALS, INC. Dated as of May 19, 2015 TABLE OF CONTENTS (Filed With SEC on August 10, 2015)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. INVESTOR AGREEMENT Byand Between JOHNSON &... (Filed With SEC on August 10, 2015)

ACHILLION PHARMACEUTICALS, INC. 2015 STOCK INCENTIVE PLAN (Filed With SEC on June 8, 2015)

ACHILLION PHARMACEUTICALS, INC. (a Delaware corporation) 12,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 12, 2015)

MASTER SECURITY AGREEMENT dated as of October 3, 2014 (Agreement) (Filed With SEC on October 6, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on May 30, 2013)

ACHILLION PHARMACEUTICALS, INC. (a Delaware corporation) 15,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 22, 2013)

ACHILLION PHARMACEUTICALS, INC. 2006 STOCK INCENTIVE PLAN (Filed With SEC on February 20, 2013)

[SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT] 2 (Filed With SEC on November 8, 2012)

ACHILLION PHARMACEUTICALS, INC. $50,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on November 8, 2012)

[SIGNATURE PAGE TO SUBSCRIPTION AGREEMENT] 2 (Filed With SEC on August 31, 2012)

ACHILLION PHARMACEUTICALS, INC. 2006 STOCK INCENTIVE PLAN (Filed With SEC on August 8, 2012)

ACHILLION PHARMACEUTICALS, INC. June 5, 2012 (Filed With SEC on August 8, 2012)

ACHILLION PHARMACEUTICALS, INC. (a Delaware corporation) 9,600,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 22, 2011)

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 8, 2011)

EMPLOYMENT AGREEMENT (Filed With SEC on April 8, 2011)

MASTER SECURITY AGREEMENT dated as of March 21, 2011(Agreement) (Filed With SEC on March 25, 2011)

AMENDMENT NO. 2 TO LEASE (Filed With SEC on April 6, 2010)

Confidential Materials omittedand filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on March 11, 2010)

SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2010)

ACHILLION PHARMACEUTICALS, INC. 2006 STOCK INCENTIVE PLAN (Filed With SEC on March 11, 2010)

ACHILLION PHARMACEUTICALS, INC. 2006 EMPLOYEE STOCK PURCHASEPLAN (Filed With SEC on March 11, 2010)

ACHILLION PHARMACEUTICALS, INC. 10,275,000 Shares ofCommon Stock UNDERWRITING AGREEMENT January 22, 2010 (Filed With SEC on January 22, 2010)

SURRENDER AND TERMINATION AGREEMENT (Filed With SEC on December 22, 2009)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Astersisks denoteomissions. (Filed With SEC on November 6, 2009)

Confidential Materials omitted and filed separately with the (Filed With SEC on August 3, 2009)

STANDBY EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on July 6, 2009)

EMPLOYMENT AGREEMENT (Filed With SEC on January 8, 2009)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on May 7, 2008)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 5, 2008)

WARRANT TO PURCHASE 21,368 SHARES OF COMMON STOCK (Filed With SEC on March 5, 2008)

PROMISSORY NOTE June 30, 2003 (Date) (Filed With SEC on March 5, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on November 27, 2007)

PROMISSORY NOTE June 28, 2007 (Filed With SEC on August 8, 2007)

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on March 29, 2007)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 29, 2007)

Achillion Pharmaceuticals, Inc. Nonstatutory Stock Option Agreement (Filed With SEC on December 26, 2006)

W I T N E S S E T H: (Filed With SEC on October 10, 2006)

Shares ACHILLION PHARMACEUTICALS, INC. Common Stock (Filed With SEC on September 22, 2006)

[Achillion logo] ACHILLION PHARMACEUTICALS, INC. INCORPORATED UNDER THE LAWS OF THE STATE OFDELAWARE (Filed With SEC on September 22, 2006)

Securities and Exchange Commission. Asterisks denote omissions. RESEARCH COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on September 22, 2006)

ACHILLION PHARMACEUTICALS, INC. (Filed With SEC on September 22, 2006)

STOCK SUBSCRIPTION WARRANT To Purchase 233,000 Shares of Common Stock of (Filed With SEC on September 22, 2006)

PROMISSORY NOTE (Filed With SEC on September 1, 2006)

Shares ACHILLION PHARMACEUTICALS, INC. Common Stock (Filed With SEC on June 6, 2006)

SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 17, 2006)

THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (Filed With SEC on May 17, 2006)

PROMISSORY NOTE (Filed With SEC on May 17, 2006)

ACHILLION PHARMACEUTICALS, INC. (Filed With SEC on May 17, 2006)

Achillion Pharmaceuticals, Inc. (Filed With SEC on May 17, 2006)

ACHILLION PHARMACEUTICALS, INC. (Filed With SEC on May 17, 2006)

PROMISSORY NOTE (Filed With SEC on May 17, 2006)

Category

Industry

Companies

Contracts

ACHILLION PHARMACEUTICALS INC Contracts & Agreements